Brief: Lee's Pharmaceutical Says Socazolimab Obtained Phase III Clinical Trial Approval From NMPA
05/03/2021 15:15
March 5 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* SOCAZOLIMAB OBTAINED APPROVAL FOR A PHASE III CLINICAL
TRIAL
FROM NMPA
Source text https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0305/2021030501425.pdf
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA